Early sepsis detection: The critical role of biomarkers

In this video, Dr. Elena Sukhacheva from Beckman Coulter discusses the recently FDA-approved sepsis biomarker that can aid in early sepsis detection. The biomarker is part of a scientific effort to help clinicians worldwide detect sepsis early, which is critical for effective treatment and successful patient recovery. Whilst there is no single best biomarker for sepsis, combining biomarkers with clinical information from the hospital along with the use of diagnostic algorithms can help identify patients who need further differential diagnosis. Beckman Coulter is working towards biomarkers with high levels of sensitivity and specificity, that are cost-effective and can be made available for the majority of patients.

This video was filmed at ECCMID 2023, Copenhagen.